WEBSITECHANGES

Website Changes

---

10/08/2008

Target Acquired: It may become possible to vaccinate against brain tumours

---

10/06/2008

Urbana quilt project raises money for brain cancer research

---

10/06/2008

UCSF surgeon changes study of brain tumors

---

10/04/2008

Proton Radiation Appears to Lower Risk for Secondary Cancers

---

10/04/2008

Efficacy of a phase II vaccine targeting Cytomegalovirus antigens in newly diagnosed GBM.

---

10/04/2008

Prospective phase II trial for recurrent high-grade gliomas with capacitive coupled low radiofrequency (LRF) hyperthermia.

---

10/04/2008

A phase II trial with cetuximab, bevacizumab, and irinotecan for patients with primary glioblastomas and progression after radiation therapy and temozolamide.

---

10/04/2008

Phase I/II study of cetuximab plus temozolomide as radiochemotherapy for primary glioblastoma (GERT)

---

10/04/2008

Role of a second chemotherapy in recurrent malignant glioma patients who progress on a bevacizumab-containing regimen.

---

10/04/2008

A phase II, randomized, non-comparative clinical trial of the effect of bevacizumab (BV) alone or in combination with irinotecan (CPT) on 6-month progression free survival (PFS6) in recurrent, treatment-refractory glioblastoma (GBM).

---

10/04/2008

Effect of EGFRvIII-targeted vaccine (CDX-110) on immune response and TTP when given with simultaneous standard and continuous temozolomide in patients with GBM.

---

10/04/2008

Phase II trial of talampanel in conjunction with standard radiation (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM).

---

10/04/2008

Update on survival from the original phase II trial of bevacizumab and irinotecan in recurrent malignant gliomas.

---

10/04/2008

Phase II study of bevacizumab and etoposide in patients with recurrent malignant glioma.

---

10/04/2008

A retrospective single institutional analysis of bevacizumab and chemotherapy versus non-bevacizumab treatments for recurrent glioblastoma.

---

10/04/2008

Patterns of relapse and prognosis after bevacizumab (BEV) failure in recurrent glioblastoma (GBM).

---

10/04/2008

NY Islanders Fundraiser for Brain Tumor Research

---

10/03/2008

A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

---

10/03/2008

TMZ-BioShuttle - a reformulated Temozolomide.

---

10/03/2008

Persistent outpatient hyperglycemia is independently associated with decreased survival after primary resection of malignant brain astrocytomas.

---

10/03/2008

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children`s Oncology Group.

---

10/03/2008

Radiosurgery and carcinogenesis risk.

---

10/03/2008

Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas.

---

10/03/2008

Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.

---

09/30/2008

Maureen’s Autumn Days Calendar Raffle - to benefit brain cancer patients who need financial assistance

---